S1PR3 and acute promyelocytic leukemia: It is postulated to be a target gene in all-trans-retinoic acid (RA) treatment of acute promyelocytic leukemia [195], where as sphingosine-1-phosphate receptor 3 belongs to the EDG (endothelial differentiation gene) receptor family of g protein coupled receptors.